Novo Nordisk India head eyes 2026 weight-loss drug Wegovy launch

Published On 2023-10-03 09:54 GMT   |   Update On 2023-10-03 09:54 GMT

Danish drugmaker Novo Nordisk aims to bring its blockbuster weight-loss drug Wegovy to India in 2026, after securing regulatory approvals and ensuring it has enough supply to meet demand, a top company official told Reuters.The market opportunity for the drug is huge in the world's most populous country, where obesity rates are high especially among women. Illegal copycat versions of Wegovy...

Login or Register to read the full article

Danish drugmaker Novo Nordisk aims to bring its blockbuster weight-loss drug Wegovy to India in 2026, after securing regulatory approvals and ensuring it has enough supply to meet demand, a top company official told Reuters.

The market opportunity for the drug is huge in the world's most populous country, where obesity rates are high especially among women. Illegal copycat versions of Wegovy are already being sold through online sites.

For more details, check out the link given below:

Novo Nordisk Eyes To Bring Blockbuster Weight-Loss Drug Wegovy To India In 2026


Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News